| Date Filed | Type | Description |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 79,600 options to buy
@ $0.33, valued at
$26.3k
|
|
| 05/18/2022 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 33,000 options to buy
@ $4.52, valued at
$149.2k
|
|
| 06/17/2021 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 58,200 options to buy
@ $2.07, valued at
$120.5k
|
|
| 05/14/2021 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 23,000 options to buy
@ $6.8, valued at
$156.4k
|
|
| 07/16/2020 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 22,200 options to buy
@ $12.62, valued at
$280.2k
|
|
| 05/22/2020 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 40,500 options to buy
@ $7.3, valued at
$295.7k
|
|
| 06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 24,000 options to buy
@ $12.54, valued at
$301k
|
|
| 12/27/2018 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $1.9, valued at
$9.5k
Bought 5,000 shares
@ $1.85, valued at
$9.3k
|
|
| 11/13/2018 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 10,000 shares
@ $3.15, valued at
$31.5k
|
|
| 09/05/2018 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 128,981 options to buy
@ $3.88, valued at
$500.4k
|
|
| 09/05/2018 |
3
| CATLIN AVERY W (Director) has filed a Form 3 on Provention Bio, Inc. |
| 05/29/2018 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 34,000 options to buy
@ $5.93, valued at
$201.6k
|
|
| 05/26/2017 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.|
Txns:
| Granted 30,500 options to buy
@ $6.75, valued at
$205.9k
|
|
| 05/12/2017 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc. |
| 11/22/2016 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc. |
| 09/07/2016 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $2.8, valued at
$28k
|
|
| 06/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2016 |
4
| CATLIN AVERY W (Director) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc. |
| 03/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2012 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $5.69, valued at
$512.1k
|
|
| 08/10/2011 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $2.39, valued at
$4.8k
|
|
| 08/08/2011 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 80,000 options to buy
@ $2.8, valued at
$224k
|
|
| 09/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2010 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $4.5, valued at
$405k
|
|
| 12/01/2009 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $4.408, valued at
$4.4k
|
|
| 01/08/2009 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc. |
| 01/05/2009 |
4
| CATLIN AVERY W (Sr. VP & CFO) has filed a Form 4 on Celldex Therapeutics, Inc. |